Company Tryp Therapeutics Inc. OTC Markets
Equities
TRYPF
CA89854F1062
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0562 USD | +32.24% | +14.69% | +64.81% |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 439,423,066 | 392,449,835 ( 89.31 %) | 0 | 89.31 % |
Company contact information
Tryp Therapeutics, Inc.
1665 Ellis Street Suite 301
V1Y 2B3, Kelowna
+833-811-8797
http://tryptherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.62% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- TYP Stock
- TRYPF Stock
- Company Tryp Therapeutics Inc.